Lescarden Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Lescarden Inc.

Lescarden Inc. | Cash Flow

Fiscal year is June-May. All values USD Thousands.

2012

2013

2014

2015

2016

Net Income before Extraordinaries

185.50

257.40

176.20

193.20

112.70

Funds from Operations

185.50

257.40

176.20

193.20

112.70

Changes in Working Capital

22.30

15.60

2.10

48.80

69.80

Net Operating Cash Flow

163.20

273.10

174.10

242.00

43.00

Issuance/Reduction of Debt, Net

195.00

115.00

100.00

268.80

10.00

Net Financing Cash Flow

195.00

315.00

100.00

268.80

10.00

Net Change in Cash

31.80

41.90

74.10

26.80

33.00

Free Cash Flow

163.20

273.10

174.10

242.00

43.00

Change in Capital Stock

200.00

About Lescarden

View Profile

Address	420 Lexington Avenue New York New York 10170 United States
Employees	-
Website	http://www.catrix.com
Updated	07/08/2019
Lescarden, Inc. is a biotechnology company, which engages in the provision of development of natural, biologic therapies for the chronic wound care, dermatology and osteoarthritis markets. It focuses on research and development of biologic materials with focus on wound healing, clinical skin care, osteoarthritis and cancer applications. The company was founded by John Fletcher Prudden in 1960 and is headquartered in New York, NY.